Skip to main content

Advertisement

Open Peer Review Reports for: RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial

Back to article

Pre-publication versions of this article are available by contacting editorial@trialsjournal.com.

Original Submission
27 Jul 2018 Submitted Original manuscript
21 Aug 2018 Reviewed Reviewer Report - Susan Dutton
17 Sep 2018 Author responded Author comments - Sean Lim
Resubmission - Version 2
17 Sep 2018 Submitted Manuscript version 2
Publishing
16 Oct 2018 Editorially accepted
9 Nov 2018 Article published 10.1186/s13063-018-2996-6

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement